Fibrous Polymers for the Delivery of Contraceptive Steroids to the Female Reproductive Tract
Chapter
Abstract
Research and development on the application of controlled-release technology to fertility regulation was initiated in the late 1960s and has been accelerated in recent years.1’2 Since sustained-release doses obviate the problem of cyclic overdosing and underdosing associated with the conventional administration of steroids, the technology, in principle, affords a means of effecting an optimum pharmacological response with a minimum dose of exogenous steroid.3 Depending upon the half-life of the drug in plasma, the duration of the dose regimen, and the route of administration, the total dose can be reduced to 1/100 or less for continuous versus intermittant delivery.
Keywords
Female Reproductive Tract Contraceptive Steroid Sheath Thickness Polyethylene Fiber Core Matrix
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.G.W. Duncan and D.R. Kalkwarf, in: “Human Reproduction: Conception and Contraception,” E.S.E. Hafez and T.N. Evans, eds., Harper and Row, New York, (1975). pp. 483–503.Google Scholar
- 2.H.L. Gabelnick, ed., “Drug Delivery Systems,” Workshop Sponsored by NICHD, Bethesda, Maryland, August 2–3, (1976).Google Scholar
- 3.D.R. Cowsar, in: “Controlled Release of Biologically Active Agents,” A.C. Tanquary and R.E. Lacey, eds., Plenum Press, New York, (1974). pp. 1–13.CrossRefGoogle Scholar
- 4.L.R. Beck, D.R. Cowsar, and V.Z. Pope, Research Frontiers in Fertility Regulation 1 (1): 1 (1980).PubMedGoogle Scholar
- 5.
- 6.M. Haefeli, W. Zodraw, U.S. Spornitz, K.S. Ludwig, and A. Wetwillor, in: “Medicated IUDs and Polymeric Delivery Ststems: International Symposium,” E.S.E. Hafez and W. Van Os, eds., Abstract 3, June 27–30 (1979).Google Scholar
- 7.H.J. Tatum, Fertility and Sterility 28 (1): 3 (1977).PubMedGoogle Scholar
- 8.B.B. Pharris and P. Rowe, in: “Medicated IUDs and Polymeric Delivery Systems: International Symposium,” E.S.E. Hafez and W. Van Os, eds., Abstract 4, June 27–30 (1979).Google Scholar
- 9.C.G. Nilsson, in: “Medicated IUDs and Polymeric Delivery Systems: International Symposium,” E.S.E. Hafez and W. Van Os, eds., Abstract 7, June 27–30 (1979).Google Scholar
- 10.P.T. Piotrow, W. Rinehart, and J.C. Schmidt, Population Reports, Series B, No. 3 (1979).Google Scholar
- 11.
- 12.H.W. Rudel, F.A. Kind, afld M.R. Henzl, in: “Birth Control-Contraception and Abortion,” H.W. Rudel, F.A. Kind, and M.R. Henzl, eds., Macmillan Company, New York, (1973). pp. 154185.Google Scholar
- 13.R.W. Baker and H.K. Lonsdale, in: “Controlled Release of Biologically Active Agents,” A.C. Tanugary and R.E. Lacey, eds., Plenum Press, New York (1975). pp. 15–71.Google Scholar
- 14.D.H. Lewis and D.R. Cowsar, in: “Controlled Release Pesticides,” H.B. Scher, ed., American Chemical Society. ACS Symposium Series, No. 53 (1977). pp. 1–16.CrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media New York 1981